The Stern Cardiovascular Foundation

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Heart failure3 trials
• Coronary artery disease2 trials
• Stroke2 trials
• Obesity1 trial

Phase

• Phase 33 trials

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Eli Lilly and Company1 trial
• Impulse Dynamics1 trial
• Medtronic Cardiac Rhythm and Heart Failure1 trial

Running trials

• Active, not recruiting

  An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  NCT07517263· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Assessment of CCM in HF With Higher Ejection Fraction

  NCT05064709· Impulse Dynamics· Source

  Contact: Kristen Page

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting

Closed trials

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

  NCT04847557· Phase 3· Eli Lilly and Company· Source

• Completed

  Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

  NCT04452149· Medtronic Cardiac Rhythm and Heart Failure· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· Phase 3· Novartis Pharmaceuticals· Source